GlassScriptPhysician profile
Michael Ferrandino
NPI 1962611905
$16,265.36
in general payments reported to CMS, 2019-2025
44 companies · $1,451 in 2025
The $1,451 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2020: $1,600 · 2021: $2,563 · 2022: $2,070 · 2023: $907 · 2024: $7,501 · 2025: $1,451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,600 · Food and Beverage: $3,592 · Travel and Lodging: $556 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,600.00 |
| Food and Beverage | $3,592.22 |
| Travel and Lodging | $556.39 |
| Education | $111.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arrow International, INC. | $6,156.39 | 2024 | Deknatel |
| Teleflex LLC | $5,090.72 | 2020-2025 | Barrigel, Urolift, Deknatel |
| Sumitomo Pharma America, INC. | $852.45 | 2023-2025 | Orgovyx, Gemtesa |
| Medtronic, INC. | $754.71 | 2021 | |
| Janssen Biotech, INC. | $378.97 | 2023-2025 | Erleada, Akeega |
| Pfizer INC. | $283.04 | 2023-2025 | |
| Astellas Pharma US INC | $275.69 | 2019-2025 | Xtandi, Padcev |
| Olympus America INC. | $257.07 | 2022-2025 | Itind System, Shockpulse |
| Abbvie INC. | $208.27 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $202.31 | 2019-2025 | Welireg, Keytruda, Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $190.38 | 2023-2025 | |
| Intuitive Surgical, INC. | $187.45 | 2019-2024 | |
| Teleflex Medical Incorporated | $156.71 | 2024 | Percutaneous: Percuvance System |
| Boston Scientific Corporation | $122.47 | 2021-2023 | Rezum Generator |
| Myovant Sciences INC. | $118.54 | 2022 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $103.58 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Ferring Pharmaceuticals INC. | $98.62 | 2024-2025 | Adstiladrin |
| Convatec INC. | $94.66 | 2025 | |
| Axonics, INC. | $62.53 | 2022-2023 | Bulkamid, Axonics |
| Urogen Pharma, INC. | $61.47 | 2023-2024 | |
| Conmed Corporation | $60.09 | 2022 | |
| Dendreon Pharmaceuticals LLC | $57.44 | 2023-2024 | Provenge |
| Endo Pharmaceuticals INC. | $44.11 | 2022-2023 | Xiaflex, Aveed |
| Cook Medical LLC | $42.73 | 2024-2025 | Cook |
| Dentsply Ih Ab | $41.96 | 2023-2025 | Lofric, Lofric |
| Cardinal Health 414 LLC | $36.06 | 2025 | Kit For The Preparation of Lymphoseek (Technetium Tc 99m Tilmanocept) |
| Baxter Healthcare | $35.13 | 2024 | Tisseel |
| Telix Pharmaceuticals | $31.74 | 2024 | Illuccix |
| Progenics Pharmaceuticals, INC. | $28.82 | 2024 | |
| Innovation Technologies INC | $25.38 | 2025 | Irrisept |
| Biotissue Holdings INC. | $23.55 | 2025 | |
| Steris Corporation | $23.54 | 2025 | |
| Sun Pharmaceutical Industries INC. | $20.90 | 2025 | |
| Hollister Incorporated | $20.70 | 2023 | Vapro |
| Coloplast Corp | $20.58 | 2023 | Speedicath |
| Histosonics, INC. | $20.57 | 2025 | |
| Procept Biorobotics Corporation | $17.36 | 2024 | Aquabeam System |
| Immunitybio, INC. | $16.65 | 2024 | |
| Tolmar, INC. | $14.49 | 2024 | |
| Abc Home Medical Supply, INC. | $14.45 | 2025 | |
| Myriad Genetic Laboratories, INC. | $13.08 | 2023 | Prolaris |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ferrandino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.